Quell Wearable Pain Relief Technology, a commercial transcutaneous electrical nerve stimulation device, has recently been awards a US patent. The device uses sensors to automatically adjust stimulation for optimal comfort and pain relief. Described as a novel application of real-time accelerometer measurements to control transcutaneous electrical nerve stimulation, the core technology enables features that include automatic adjustment of stimulation while the user is sleeping. It is also said to be the only transcutaneous electrical nerve stimulator on the market that incorporates advanced sensor technologies, such as accelerometers, to regulate neurostimulation and optimize relief from chronic pain.
Designed for people suffering from chronic pain, the wearable device is lightweight and can be worn during the day while active, and at night while sleeping. It has been cleared by the FDA for treatment of chronic pain without a prescription. In a recent study, 81% of Quell users reported an improvement in their chronic pain. Quell users can personalize and manage therapy discreetly via the Quell Relief app. Quell also offers advanced health tracking relevant to chronic pain sufferers including pain, sleep, activity, and gait. Quell was the winner of the 2016 SXSW (South by Southwest) Innovation Award for Best Wearable Technology. Quell is available at select healthcare professionals and retailers. For more info, visit https://www.quellrelief.com and http://www.neurometrix.com